<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kuznar, Wayne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Brusko, Todd M.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Cellular-Based Strategies, Closed-Loop Algorithms Are Latest Developments in Therapy for Type 1 Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">6-7</style></pages><abstract><style  face="normal" font="default" size="100%">Cell-replacement strategies to preserve insulin production and closed-loop continuous glucose monitoring and insulin delivery systems are attractive options for exogenous insulin delivered through several daily injections for patients with type 1 diabetes (T1D). This article discusses advances in cellular-based therapies for T1D, update of closed-loop therapy, the cost of research efforts to find a cure, as well as reviews attempts to prevent the development of T1D.</style></abstract><number><style face="normal" font="default" size="100%">11</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>